Literature DB >> 10854325

Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor.

K Burns1, J Clatworthy, L Martin, F Martinon, C Plumpton, B Maschera, A Lewis, K Ray, J Tschopp, F Volpe.   

Abstract

Interleukin-1 (IL-1) is a proinflammatory cytokine that elicits its pleiotropic effects through activation of the transcription factors NF-kappaB and AP-1. Binding of IL-1 to its receptor results in rapid assembly of a membrane-proximal signalling complex that consists of two different receptor chains (IL-1Rs), IL-1RI and IL-1RAcP, the adaptor protein MyD88, the serine/threonine kinase IRAK and a new protein, which we have named Tollip. Here we show that, before IL-1beta treatment, Tollip is present in a complex with IRAK, and that recruitment of Tollip-IRAK complexes to the activated receptor complex occurs through association of Tollip with IL-1RAcP. Co-recruited MyD88 then triggers IRAK autophosphorylation, which in turn leads to rapid dissociation of IRAK from Tollip (and IL-1Rs). As overexpression of Tollip results in impaired NF-kappaB activation, we conclude that Tollip is an important constituent of the IL-1R signalling pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854325     DOI: 10.1038/35014038

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  134 in total

1.  Proteins of the endoplasmic-reticulum-associated degradation pathway: domain detection and function prediction.

Authors:  C P Ponting
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase.

Authors:  Shyun Li; Astrid Strelow; Elizabeth J Fontana; Holger Wesche
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

3.  Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis.

Authors:  Javeed A Shah; Jay C Vary; Tran T H Chau; Nguyen D Bang; Nguyen T B Yen; Jeremy J Farrar; Sarah J Dunstan; Thomas R Hawn
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

Review 4.  Deciphering the complexity of Toll-like receptor signaling.

Authors:  Renato Ostuni; Ivan Zanoni; Francesca Granucci
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

5.  Differential regulation of Toll-like receptor signalling in spleen and Peyer's patch dendritic cells.

Authors:  Julie M Davies; John MacSharry; Fergus Shanahan
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

6.  Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.

Authors:  Yi Liu; Xiao-Li Jiang; Yu Liu; Ding-Sheng Jiang; Yan Zhang; Rui Zhang; Yingjie Chen; Qinglin Yang; Xiao-Dong Zhang; Guo-Chang Fan; Hongliang Li
Journal:  Cardiovasc Res       Date:  2013-11-26       Impact factor: 10.787

7.  Toll-Interacting Protein, Tollip, Inhibits IL-13-Mediated Pulmonary Eosinophilic Inflammation in Mice.

Authors:  Yoko Ito; Niccolette Schaefer; Amelia Sanchez; David Francisco; Rafeul Alam; Richard J Martin; Julie G Ledford; Connor Stevenson; Di Jiang; Liwu Li; Monica Kraft; Hong Wei Chu
Journal:  J Innate Immun       Date:  2018-01-27       Impact factor: 7.349

8.  Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis.

Authors:  Nian Wan; Xiaoxiong Liu; Xiao-Jing Zhang; Yichao Zhao; Gangying Hu; Fengwei Wan; Rui Zhang; Xueyong Zhu; Hao Xia; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

9.  CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells.

Authors:  Kei Ohnuma; Tadanori Yamochi; Masahiko Uchiyama; Kunika Nishibashi; Satoshi Iwata; Osamu Hosono; Hiroshi Kawasaki; Hirotoshi Tanaka; Nam H Dang; Chikao Morimoto
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

10.  Leishmania major abrogates gamma interferon-induced gene expression in human macrophages from a global perspective.

Authors:  Nisha Dogra; Corinna Warburton; W Robert McMaster
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.